Nanoprobes Enable Measurement of T-Cell Binding Forces
By LabMedica International staff writers Posted on 02 Jun 2016 |

Image: A three-dimensional rendering of a fluorescence image maps the piconewton forces applied by T-cells. The height and color indicates the magnitude of the applied force (Photo courtesy of Yang Liu, Emory University).
A team of biochemical engineers has demonstrated that activation of immune system T-cells by foreign antigens has a physical component that is just as important to the process as immunochemical recognition.
T-cells are triggered when the T-cell receptor (TCR) encounters its antigenic ligand, the peptide-major histocompatibility complex (pMHC), on the surface of antigen presenting cells (APCs). Because T-cells are highly migratory and antigen recognition occurs at a junction where the T-cell physically contacts the APC, there are long-standing questions of whether T-cells transmit defined forces to their TCR complex and whether biophysical coupling influences immune function.
In an attempt to answer these questions investigators at Emory University (Atlanta, GA, USA) developed DNA-based gold nanoparticle tension sensors that fluoresce in response to a mechanical force as small as one piconewton (10 to the minus 12 newtons). The investigators designed a series of experiments in which mouse T-cells interacted with a series of eight amino acid peptide ligands that differed in the number four amino acid position. The amount of force that was applied by the T-cell was mapped using tension probes of different reactivity. Probes that responded to greater than 19 piconewtons did not fluoresce, while probes that reacted to less than 12 piconewtons produced a high signal. Video obtained through a fluorescent microscope enabled the investigators to measure and record the responses of the T-cells as they moved across the ligands.
Results published in the May 2, 2016, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences revealed that naïve T-cells harnessed cytoskeletal coupling to transmit from 12-19 piconewtons of force to their TCRs within seconds of ligand binding and preceding initial calcium signaling. CD8 coreceptor binding and lymphocyte-specific kinase signaling were required for antigen-mediated cell spreading and force generation. T-cells displayed a dampened and poorly specific response to antigen agonists when TCR forces were chemically abolished or physically adjusted to a level below about12 piconewtons.
"We have provided the first direct evidence that a T-cell gives precise mechanical tugs to other cells," said senior author Dr. Khalid Salaita, professor of chemistry at Emory University. "And we have shown that these tugs are central to a T-cell's process of deciding whether to mount an immune response. A tug that releases easily, similar to a casual handshake, signals a friend. A stronger grip indicates a foe."
"As a T-cell moves across a cell's surface and encounters a ligand, it pulls on it," said Dr. Salaita. "It does not pull very hard; it is a very precise and tiny tug that is not sustained. The T-cell pulls and stops, pulls and stops, all across the surface. It is like the T-cell is doing a mechanical test of the ligand. If you view this T-cell response purely as a chemical process, it does not fully explain the remarkable specificity of the binding. When you take the two components - the TCR and the ligand on the surface of cells - and just let them chemically bind in a solution, for example, you cannot predict what will trigger a strong or a weak immune response."
Related Links:
Emory University
T-cells are triggered when the T-cell receptor (TCR) encounters its antigenic ligand, the peptide-major histocompatibility complex (pMHC), on the surface of antigen presenting cells (APCs). Because T-cells are highly migratory and antigen recognition occurs at a junction where the T-cell physically contacts the APC, there are long-standing questions of whether T-cells transmit defined forces to their TCR complex and whether biophysical coupling influences immune function.
In an attempt to answer these questions investigators at Emory University (Atlanta, GA, USA) developed DNA-based gold nanoparticle tension sensors that fluoresce in response to a mechanical force as small as one piconewton (10 to the minus 12 newtons). The investigators designed a series of experiments in which mouse T-cells interacted with a series of eight amino acid peptide ligands that differed in the number four amino acid position. The amount of force that was applied by the T-cell was mapped using tension probes of different reactivity. Probes that responded to greater than 19 piconewtons did not fluoresce, while probes that reacted to less than 12 piconewtons produced a high signal. Video obtained through a fluorescent microscope enabled the investigators to measure and record the responses of the T-cells as they moved across the ligands.
Results published in the May 2, 2016, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences revealed that naïve T-cells harnessed cytoskeletal coupling to transmit from 12-19 piconewtons of force to their TCRs within seconds of ligand binding and preceding initial calcium signaling. CD8 coreceptor binding and lymphocyte-specific kinase signaling were required for antigen-mediated cell spreading and force generation. T-cells displayed a dampened and poorly specific response to antigen agonists when TCR forces were chemically abolished or physically adjusted to a level below about12 piconewtons.
"We have provided the first direct evidence that a T-cell gives precise mechanical tugs to other cells," said senior author Dr. Khalid Salaita, professor of chemistry at Emory University. "And we have shown that these tugs are central to a T-cell's process of deciding whether to mount an immune response. A tug that releases easily, similar to a casual handshake, signals a friend. A stronger grip indicates a foe."
"As a T-cell moves across a cell's surface and encounters a ligand, it pulls on it," said Dr. Salaita. "It does not pull very hard; it is a very precise and tiny tug that is not sustained. The T-cell pulls and stops, pulls and stops, all across the surface. It is like the T-cell is doing a mechanical test of the ligand. If you view this T-cell response purely as a chemical process, it does not fully explain the remarkable specificity of the binding. When you take the two components - the TCR and the ligand on the surface of cells - and just let them chemically bind in a solution, for example, you cannot predict what will trigger a strong or a weak immune response."
Related Links:
Emory University
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more
New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
Drug-induced kidney injury, also known as nephrotoxicity, is a prevalent issue in clinical practice, occurring when specific medications at certain doses cause damage to the kidneys. Nephrotoxicity can... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
Tecan Group (Männedorf, Switzerland) has entered into an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS (Codolet, France), a subsidiary of the... Read more